Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion imaging

American Journal of Cardiology

Volumn 89, Issue 8, 2002, Pages 964-968

  Elhendy, Abdou ^b,c   Van Domburg, Ron T ^a   Vantrimpont, Pascal ^a   Poldermans, Don ^a   Bax, Jeroen J ^a   Van Gelder, Teun ^a   Baan, Carla C ^a   Roelandt, Jos R T C ^a   Balk, Aggie H M M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DOBUTAMINE; METOPROLOL; TETROFOSMIN TC 99M;

ADULT; AGE; ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EXERCISE TEST; FEMALE; FOLLOW UP; GENDER; GRAFT REJECTION; HEART DEATH; HEART GRAFT; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OPERATION DURATION; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGICAL MORTALITY; SURGICAL RISK;

ECHOCARDIOGRAPHY, STRESS; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0037090496     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02247-6     Document Type: Article

References (20)

1. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging
2. Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain
3. Dobutamine stress myocardial perfusion imaging
4. The results of cardiac retransplantation: An analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry
5. Diagnosis and treatment of cytomegalovirus infection
6. Accuracy of dobutamine tetrofosmin myocardial perfusion imaging for the noninvasive diagnosis of transplant coronary artery stenosis
7. Exercise-induced hypotension in a male population. Criteria, causes, and prognosis
8. Prognostic significance of systolic blood pressure changes during dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain and known or suspected coronary artery disease
9. Myocardial perfusion scintigraphy in heart transplant recipients with and without allograft atherosclerosis: A comparison of thallium-201 and technetium 99m sestamibi
10. Coronary artery disease after heart transplantation: Non-invasive evaluation with exercise thallium scintigraphy
11. Progressive heterogeneity of myocardial perfusion in heart transplant recipients detected by thallium-201 myocardial SPECT
12. Evaluation of 201Tl SPECT myocardial perfusion imaging in the detection of coronary artery disease after orthotopic heart transplantation
13. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant
14. Prognostic value of noninvasive testing one year after orthotopic cardiac transplantation
15. Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation
16. Role of dobutamine stress echocardiography in heart transplant patients
17. Dobutamine echocardiography for prediction of ischemic events in heart transplant recipients
18. Dobutamine stress echocardiography predicts cardiac events in heart transplant patients
19. Dobutamine stress echocardiography in orthotopic heart transplant recipients
20. Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men